Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for complement activation, alternative pathway (biogroup)
Most Correlated Studies
- L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
- L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
- L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
- L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
- Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) expression profiles
Most Relevant Literature
- The tick-over theory revisited: is C3 a contact-activated protein?
- Acute postinfectious glomerulonephritis].
- Complement activation via alternative pathway is critical in the development of laser-induced choroi…
- An approach to research on nephritic factor and membranoproliferative glomerulonephritis].
- Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum…
Most Relevant Clinical Trials
- Complement Inhibition in aHUS Dialysis Patients
- Study of the Link Between Complement Activation and IgA Nephropathy Severity
- First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
- Lectine Pathway in Unstable Carotid Plaque
- Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidne…
